Can Wegovy Cause a Cough? What the Evidence Shows

What the STEP 1 trial and the SmPC say about respiratory symptoms

The most direct way to answer this is to look at where the evidence comes from. The STEP 1 trial (68 weeks, nearly 2,000 adults with obesity, comparing semaglutide 2.4 mg against placebo) was the foundation for Wegovy's UK licence. Respiratory events were not among the adverse effects flagged at a meaningful frequency in that dataset. The NHS semaglutide medicines page lists the side effects ranked by how often they appeared across trials: the common and very common ones are almost entirely gastrointestinal. Cough does not appear in those tiers.

The UK Summary of Product Characteristics (available on the eMC) lists cough as a side effect occurring in fewer than 1 in 1,000 users — the "very rare" category. At that frequency, most people taking Wegovy will never notice it. What patients sometimes report, though, is a persistent throat-clearing or mild cough that they trace back to when they started semaglutide. Understanding why requires a short detour through what the medicine does to digestion.

For a broader look at how the medicine works and what its documented side effect profile covers, the Wegovy overview at nume sets out the full picture in plain terms, including guidance specific to the Wegovy 1mg dose for those earlier in their titration schedule.

Why some people link a cough to Wegovy, the reflux connection

Semaglutide slows gastric emptying. Food and stomach acid move through the digestive system more gradually, which is part of how the medicine reduces appetite. The knock-on effect for some people is that acid is more likely to sit at the top of the stomach or travel back up into the oesophagus, especially when lying down or after eating a larger meal than their new appetite expected.

Acid reaching the throat (a condition sometimes called laryngopharyngeal reflux) can trigger a dry, irritating cough with no obvious respiratory cause. It is the same mechanism behind the "silent reflux" that many people experience without heartburn at all. This is not the same as a Wegovy-caused cough in a direct pharmacological sense; it is a downstream consequence of the GI changes the medicine produces.

That distinction matters practically. If you notice throat irritation or coughing after starting treatment, adjusting meal size, sitting upright for a couple of hours after eating and avoiding late meals may help considerably. Your prescriber can also review whether a short course of an antacid or a proton pump inhibitor is appropriate. If you are curious about the broader range of gastrointestinal effects people ask about, there is a useful summary on the Wegovy and gas page.

It is honest to acknowledge that if you are reading this because you've developed a cough since starting Wegovy, the uncertainty is genuinely uncomfortable. A symptom you didn't have before is worth taking seriously, even when the numbers suggest it is unlikely to be directly drug-related.

When a cough during Wegovy treatment needs medical attention

Most throat irritation tied to reflux is mild and manageable. There are, however, situations where a cough during Wegovy treatment should be assessed promptly by a doctor rather than monitored at home.

Seek help the same day if a cough is accompanied by any of the following: severe or persistent abdominal pain that radiates to your back (which can be a sign of pancreatitis, flagged by the MHRA in a January 2026 Drug Safety Update for GLP-1 medicines); wheezing or shortness of breath; blood in sputum; or fever. A cough that develops after a new medicine is always worth reporting to whoever manages your care, even if it turns out to be coincidental. The MHRA's Yellow Card reporting tool exists precisely for this: if you suspect a side effect, logging it contributes to the UK's post-marketing surveillance and can help clarify rare signals over time.

Separately, some people notice that an existing cough from another cause (a lingering viral infection, seasonal allergies, or ACE-inhibitor use) happens to coincide with starting Wegovy. In those cases the medicine is not the culprit, but the timing makes it feel like one. A prescriber can usually unpick the timeline fairly quickly. More detail on the documented side-effect landscape is covered on the Wegovy side effects overview page.

Practical steps and when a prescriber should know

If you are already taking Wegovy and a cough has appeared, here is what the evidence supports doing. First, keep a brief note of when the cough is worst (after meals, at night, in the morning) as that pattern usually points toward reflux rather than a direct drug reaction. Second, tell your prescriber at your next review, or sooner if the cough is bothersome or worsening. They may adjust your dose titration pace, since slowing the escalation sometimes reduces GI side effects across the board.

Third, do not stop Wegovy abruptly because of a mild cough without speaking to your prescriber first; the symptom may well resolve or have a straightforward explanation. The first month on Wegovy is often when side effects are most noticeable, and many settle as the body adjusts.

For anyone still at the research stage (weighing up whether Wegovy is right for them and what the cost context looks like) the Wegovy cost page covers what a private prescription typically includes. And if you have already decided to go ahead, a free consultation with a named prescriber at nume's treatment page is the place to start. A clinician reviews your answers the same day and can discuss any existing respiratory conditions as part of the assessment.